This application aims to foster the career development of a diverse and exceptionally well trained group of pediatric endocrinologists entering the field of pediatric diabetes research through a joint institutional career development program at the Joslin Diabetes Center and Children's Hospital Boston. Through mentored training of pediatric endocrine scholars who have completed fellowships in pediatric endocrinology, this joint program will support and nurture career development of junior faculty in biomedical and behavioral diabetes investigation relevant to type 1 diabetes. Based upon the longstanding history of collaboration between the Joslin Diabetes Center and Children's Hospital Boston, our extensive diabetes research programs, and our record of successful career development of pediatric endocrinologists becoming independent diabetes researchers with support from our recently completed K12 career development grant for pediatric diabetologists, we aim to mentor a new group of pediatric endocrinologists who will become future leaders of pediatric diabetes programs in the United States. Each year we will provide career development and support for up to 3 years for 3 recent graduates of pediatric endocrinology fellowship programs. The Joslin Diabetes Center and the Children's Hospital Boston are ideally suited for this institutional career development award due to our extensive group of faculty mentors, multi-disciplinary training programs, commitment to mentoring pre- doctoral and post-doctoral fellows and junior faculty in research relevant to type 1 diabetes, and our available pool of diverse, talented candidates for appointment to the K12 program. The rationale for the application includes: the increased occurrence of both type 1 and type 2 diabetes in childhood, the need to discover the root causes of type 1 and type 2 diabetes, the challenges of achieving optimal glycemic control in youth, the high risk of short- and long-term diabetes complications, the need for additional research to increase our understanding of uncommon genetic forms of diabetes, the demands of implementing and maintaining intensive insulin therapy and new monitoring technologies in children, and the need for trained and committed pediatric diabetes investigators to advance research aimed at treating, preventing and curing these disorders. Given the history of diabetes research at our institutions and the richness of the Harvard Medical School environment, this joint application offers a unique setting for career development of pediatric endocrinologists committed to careers in pediatric diabetes. Co-Principal Investigator and Program Director Lori Laffel MD MPH and Co-Principal Investigator Morris White PhD, supported by an Advisory Committee, are in optimal positions to orchestrate this endeavor. Career development is enhanced by Joslin's NIH-supported Diabetes Research Center (formerly DERC), Harvard's CTSA, and Harvard's Catalyst Program. We have consistently demonstrated the ability to attract highly qualified candidates to our training programs and look forward to meeting the challenge of nurturing the careers of pediatric endocrinologists as pediatric diabetes investigators.
This application aims to foster the career development of a diverse and exceptionally well trained group of pediatric endocrinologists entering the field of pediatric diabetes research through a joint institutional career development program at the Joslin Diabetes Center and Children's Hospital Boston. To meet the growing biomedical and behavioral research needs for pediatric diabetes, each year we will provide career development and support for up to 3 years for 3 recent graduates of pediatric endocrinology fellowship training programs. Based upon our extensive diabetes research programs relevant to type 1 diabetes and record of successful career development of pediatric endocrinologists becoming independent diabetes researchers, we aim to support the career development of a new group of pediatric endocrinologists who will become future leaders of pediatric diabetes programs in the United States.
|Paone, Laura; Fleisch, Abby F; Feldman, Henry A et al. (2016) Liothyronine Improves Biochemical Control of Congenital Hypothyroidism in Patients with Central Resistance to Thyroid Hormone. J Pediatr 175:167-172.e1|
|Brady, Cassandra C; Thaker, Vidhu V; Lingren, Todd et al. (2016) Suboptimal Clinical Documentation in Young Children with Severe Obesity at Tertiary Care Centers. Int J Pediatr 2016:4068582|
|Fleisch, Abby F; Kloog, Itai; Luttmann-Gibson, Heike et al. (2016) Air pollution exposure and gestational diabetes mellitus among pregnant women in Massachusetts: a cohort study. Environ Health 15:40|
|Levenson, Amy E; Haas, Mary E; Miao, Ji et al. (2016) Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients. Endocrinology 157:1421-9|
|Garvey, Katharine C; Telo, Gabriela H; Needleman, Joseph S et al. (2016) Health Care Transition in Young Adults With Type 1 Diabetes: Perspectives of Adult Endocrinologists in the U.S. Diabetes Care 39:190-7|
|Fleisch, A F; Luttmann-Gibson, H; Perng, W et al. (2016) Prenatal and early life exposure to traffic pollution and cardiometabolic health in childhood. Pediatr Obes :|
|Haas, Mary E; Levenson, Amy E; Sun, Xiaowei et al. (2016) The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia. Circulation 134:61-72|
|Oken, Emily; Baccarelli, Andrea A; Gold, Diane R et al. (2015) Cohort profile: project viva. Int J Epidemiol 44:37-48|
|Rasbach, Lisa E; Volkening, Lisa K; Markowitz, Jessica T et al. (2015) Youth and parent measures of self-efficacy for continuous glucose monitoring: survey psychometric properties. Diabetes Technol Ther 17:327-34|
|Katz, M L; Volkening, L K; Dougher, C E et al. (2015) Validation of the Diabetes Family Impact Scale: a new measure of diabetes-specific family impact. Diabet Med 32:1227-31|
Showing the most recent 10 out of 27 publications